Results 11 to 20 of about 10,322,817 (363)

Tissue-specific and mosaic imprinting defects underlie opposite congenital growth disorders in mice. [PDF]

open access: yesPLoS Genet, 2018
Differential DNA methylation defects of H19/IGF2 are associated with congenital growth disorders characterized by opposite clinical pictures. Due to structural differences between human and mouse, the mechanisms by which mutations of the H19/IGF2 ...
Freschi A   +12 more
europepmc   +2 more sources

Adherence and long-term growth outcomes: results from the easypod connect observational study (ECOS) in paediatric patients with growth disorders. [PDF]

open access: yesEndocr Connect, 2018
Objective The easypod connect observational study (ECOS) assessed treatment adherence among paediatric patients receiving growth hormone (GH) via the easypod electronic injection device.
Koledova E   +3 more
europepmc   +2 more sources

Insulin-like growth factor axis in pregnancies affected by fetal growth disorders. [PDF]

open access: yesClin Epigenetics, 2016
BackgroundInsulin-like growth factors 1 and 2 (IGF1 and IGF2) and their binding proteins (IGFBPs) are expressed in the placenta and known to regulate fetal growth.
Nawathe AR   +5 more
europepmc   +2 more sources

Growth disorders among 6-year-old Iranian children. [PDF]

open access: yesIran Red Crescent Med J, 2014
Background: Sociodemographic factors are important determinants of weight disorders. National representative studies provide a view on this health problem at national and regional levels.
Kelishadi R   +6 more
europepmc   +2 more sources

Growth hormone and its disorders [PDF]

open access: bronzePostgraduate Medical Journal, 2006
Abstract Growth hormone (GH) is synthesised and secreted by the somatotroph cells of the anterior lobe of the pituitary gland. Its actions involve multiple organs and systems, affecting postnatal longitudinal growth as well as protein, lipid, and carbohydrate metabolism.
M C Sheppard, J Ayuk
openaire   +5 more sources

Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation

open access: yesHealth Technology Assessment, 2010
Background: Recombinant human growth hormone (rhGH) is licensed for short stature associated with growth hormone deficiency (GHD), Turner syndrome (TS), Prader–Willi syndrome (PWS), chronic renal insufficiency (CRI), short stature homeobox-containing ...
A Takeda   +7 more
doaj   +2 more sources

Growth disorders in type 1 diabetes: an Indian experience

open access: yesIndian Journal of Endocrinology and Metabolism, 2015
Though children with type 1 diabetes mellitus (T1DM) are often tall at the time of diagnosis, they may experience growth retardation, pubertal delay or both, which may be due to poor glycemic control, associated diseases or chronic complications. Factors
Anju Virmani
doaj   +2 more sources

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. [PDF]

open access: bronzeNew England Journal of Medicine, 1994
Lloyd Paul Aiello   +9 more
semanticscholar   +2 more sources

Screening for Growth Disorders [PDF]

open access: bronzeJournal of Medical Screening, 1994
L D Voss   +3 more
openaire   +3 more sources

Sensory systems processing in children with spastic cerebral palsy: a pilot study

open access: yesBulletin of Faculty of Physical Therapy, 2021
Background The study of the sensory aspect alongside the motor aspect in children with spastic cerebral palsy is critical. Knowledge may help improve intervention, children’s quality of life, activity, and participation.
Mennatallah Khamis AbdelHafiez Barakat   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy